Bristol-Myers Squibb Completes Sale Of Clairol To Procter & Gamble
Advertisement
NEW YORK, NEW YORK -- Bristol-Myers Squibb Company (NYSE:BMY) announced today that the sale of its Clairol beauty care subsidiary to The Procter & Gamble Company for $4.95 billion has been finalized. The divestiture, which was announced on May 21 and closed on November 15, is a key element of the company's growth strategy through a greater focus on its medicines business.
Bristol-Myers Squibb is an $18 billion pharmaceutical and related health care products company whose mission is to extend and enhance human life.